About the Journal

About us

International Journal of Clinicopathological Correlation (e-ISSN:2589-1731), a publication of MM Publishers, is a peer-reviewed online journal with Semiannual compilation of issues published. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted versions of the articles on any OAI-compliant institutional / subject-based repository.

The journal intends to publish high quality manuscripts on all aspects in the field of General Pathology from authors across the globe.

Scope of the Journal

The journal will cover technical and clinical studies related to health, ethical and social issues in the field of dental and medical specialties. Articles with clinical interest and implications will be given preference.

Frequency

The journal publishes 2 issues per year, from January to June and July to December.

Language

The journal's publication language for both articles and abstracts is English.

Article Processing Charges

Open access publication is supported by MM Publishers. International Journal of Clinicopathological correlation currently has no Article Processing Charges. There are no submission charges for the articles.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN centre, ProQuest, TDNet, Wanfang Data

Journal Ethics

IJCPC follow the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE) guidelines for best practices in publications.

Archiving

MM Publishers India will maintain all the digital archives

Instructions to the Authors

The Editorial Process

A manuscript submitted to the International Journal of Clinicopathological Correlation (IJCPC) will be reviewed for possible publication with the understanding that it is not under consideration elsewhere and has not been previously published. The journal requires authors to designate one individual to correspond with the journal on behalf of all co-authors. All submitted manuscripts are acknowledged upon receipt.

Initially, the editors review all submissions for suitability. Manuscripts lacking originality, possessing serious scientific or technical flaws, or lacking a significant message are rejected at this stage. Manuscripts unlikely to interest IJCPC readers may also be rejected at this point.

Suitable manuscripts are sent to two or more expert reviewers. Contributors are encouraged, but not required, to suggest two or three qualified reviewers who are not affiliated with the same institution. The selection of reviewers is at the editor's discretion. The journal follows a double-blind review process, ensuring that reviewers and authors remain anonymous to each other. A member of the editorial team, based on the reviewers’ comments, makes the final decision on the manuscript. Reviewers’ comments and suggestions (acceptance, rejection, or amendments) are communicated to the corresponding author. Authors may be asked to provide a point-by-point response to reviewers' comments and submit a revised manuscript. This process continues until reviewers and editors are satisfied.

Accepted manuscripts are copyedited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author, who must return corrected proofs within three days. Corrections received after this period may not be incorporated. The entire process, from submission to final decision and proof exchange, is conducted online. To facilitate rapid dissemination of knowledge, the journal publishes articles online as 'Ahead of Print' immediately upon acceptance.

Clinical trial registry

The International Journal of Clinicopathological Correlation (IJCPC) supports the registration of clinical trials and adheres to the Statement on publishing clinical trials in Indian biomedical journals. IJCPC will publish clinical trials that have been registered with a clinical trial registry providing free online access to the public. Acceptable trial registers include:

This policy applies to clinical trials that began enrolling subjects on or after June 2008. Clinical trials that started enrolling subjects before June 2008 will be considered for publication in IJCPC only if they have been retrospectively registered with a clinical trial registry that offers free online public access without any fees.

Authorship Criteria

Authorship credit should be based on substantial contributions to each of the following three components:

Concept and design of the study, acquisition of data, or analysis and interpretation of data;
Drafting the article or revising it critically for important intellectual content;
Final approval of the version to be published.

Participation solely in funding acquisition or data collection does not justify authorship. General supervision of the research group is also insufficient for authorship. Each contributor must have participated sufficiently in the work to take public responsibility for relevant portions of the manuscript's content.

The order of contributors should reflect their relative contributions to the study and manuscript preparation. Once submitted, the order of contributors cannot be changed without written consent from all contributors. The journal specifies a maximum number of authors for manuscripts based on the type of manuscript, its scope, and the number of institutions involved. Authors should provide a justification if the number of authors exceeds these limits.

Contribution Details

Contributors should provide a description of their contributions to the manuscript. The description should be divided into the following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review. One or more authors should take responsibility for the integrity of the work as a whole from inception to publication and be designated as the 'guarantor.'

Conflicts of Interest/ Competing Interests

All authors must disclose any conflicts of interest related to the publication of the manuscript or associated institutions or products. Authors should also disclose conflicts of interest with competing products mentioned in the manuscript.

Submission of Manuscripts

First-time users must register on the site. Registration is free but mandatory. Registered authors can track their articles using their username and password.

Manuscripts not following the “Instructions to Authors” will be returned to the authors for technical correction before undergoing editorial/peer review. Generally, manuscripts should be submitted as two separate files:

[1] Title Page/First Page File/covering letter:

[1] Title Page/First Page File/Covering Letter:

This file should include:

The type of manuscript (original article, case report, review article, letter to editor, images, etc.), title of the manuscript, running title, names of all authors/contributors (with their highest academic degrees, designation, and affiliations), and the department(s) and/or institution(s) to which the work should be credited. All identifying information should be included here. Use text/rtf/doc files. Do not zip the files.
The total number of pages, total number of photographs, and word counts separately for abstract and for the text (excluding references, tables, and abstract), and word counts for introduction + discussion in the case of an original article.
Source(s) of support in the form of grants, equipment, drugs, or all of these.
Acknowledgment, if any. This includes contributions needing acknowledgment but not justifying authorship, such as general support by a departmental chair, technical help, and financial and material support. This should be included on the title page of the manuscript and not in the main article file.
Information on if the manuscript was presented at a meeting (organization, place, and date).
A full statement about any submissions or previous reports that might be regarded as redundant publication of the same or similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
Registration number for clinical trials and the registry name and URL.
Conflicts of Interest for each author/contributor. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an author's form.
Criteria for inclusion in the authors'/contributors’ list.
A statement confirming that the manuscript has been read and approved by all authors and that each author believes the manuscript represents honest work.
The name, address, email, and telephone number of the corresponding author.

[2] Blinded Article file: The main text of the article, from Abstract to References (including tables), should be in this file. The file must not contain any author names, initials, or institutional affiliations. Page headers/running title can include the title but not author names. Manuscripts not complying with the Journal's blinding policy will be returned. Use rtf/doc files. Do not zip the files. Limit the file size to 1 MB. Do not incorporate images into the file. If the file size is large, submit graphs as separate images. Number the pages consecutively, beginning with the first page of the blinded article file.

[3] Images: Submit high-quality color images, each less than 2 MB. Reduce image size by decreasing the actual height and width (up to 1600 x 1200 pixels or 5-6 inches). Submit images as jpeg files. Do not zip the files. Include legends for figures/images at the end of the article file.

[4] The contributors' / copyright transfer form (template provided below) The contributors' form must be submitted in original with signatures of all contributors within two weeks of submission via courier, fax, or email as a scanned image. Print-ready hard copies of images (one set) or digital images should be sent to the journal office when submitting the revised manuscript. High-resolution images (up to 5 MB each) can be sent by email.

Preparation of Manuscripts

Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (October 2008). The uniform requirements and specific requirements of International Journal of Clinicopathological Correlation are summarized below. Before submitting a manuscript, contributors are requested to check for the latest instructions available. Instructions are also available from the website of the journal (htttp://www.mmpubl.com/ijcpc) and from the manuscript submission site (htttp://www.mmpubl.com/ijcpc).

International Journal of Clinicopathological Correlation accepts manuscripts written in American English.

Copies of any permission(s)

It is the responsibility of authors/ contributors to obtain permission for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.

Copyright Notice

The entire contents of the published journals are protected under International copyrights. MM Publishers, however, grants to all users a free, Irrevocable, worldwide, perpeutual right to access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reseanoble non-commercial purpose, subject to proper attributon of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their non-commercial use under Creative Commons Attribution-NonCommercial 4.0 International
License.

Important notice on reuse, reproduction, or commercial use: Contents of this site, partial or a whole, should not be included in a framed web page, Contents of this site, partial or as a whole, should not be included in a password -protected site or a site that requires registration, even if free, Contents of this site, partial or as a whole, should not be included in a site that charges for other contents but provides the content from this site for free.

For purchase of reprints, printable PDFs, or commercial reuse please contact MM Publishers (edmgr@mmpubl.com) or the journal editor.

Types of Manuscripts

Original articles:

These include randomized controlled trials, intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, case-control series, and surveys with high response rates. The text of original articles amounting to up to 3000 words (excluding Abstract, references, and Tables) should be divided into sections with the headings Abstract, Keywords, Introduction, Material and Methods, Results, Discussion, References, Tables, and Figure legends.

Introduction: State the purpose and summarize the rationale for the study or observation.

Materials and Methods: It should include and describe the following aspects:

Ethics: When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants, and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for or any national law on the care and use of laboratory animals were followed.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the "Materials and Methods" section.

Study design:

Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).

Reporting Guidelines for Specific Study Designs

Initiative	Type of Study	Source
CONSORT	Randomized controlled trials	http://www.consort-statement.org
STARD	Studies of diagnostic accuracy	http://www.consort-statement.org/stardstatement.htm
QUOROM	Systematic reviews and meta-analyses	http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf statement.org/Initiatives/MOOSE/moose.pdf
STROBE	Observational studies in epidemiology	http://www.strobe-statement.org
MOOSE	Meta-analyses of observational studies in epidemiology	http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf

Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra- or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.

When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.

Discussion: Include a summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis, and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research).
Do not repeat in detail data or other material given in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. New hypotheses may be stated if needed, however, they should be clearly labeled as such. About 30 references can be included. These articles generally should not have more than six authors.

Review Articles:

It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript.

The prescribed word count is up to 3000 words excluding tables, references, and abstracts. The manuscript may have about 90 references. The manuscript should have an unstructured Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review articles should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.

The journal expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of the article, and should be sent as a letter to the editor, as and when major development occurs in the field.

Case reports:

New, interesting, and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Keywords, Introduction, Case report, Discussion, Reference, Tables, and Legends in that order.

The manuscript could be of up to 1000 words (excluding references and abstract) and could be supported with up to 10 references. Case Reports could be authored by up to four authors.

Letter to the Editor:

These should be short and decisive observations. They should preferably be related to articles previously published in the Journal or views expressed in the journal. They should not be preliminary observations that need a later paper for validation. The letter could have up to 500 words and 5 references. It could be generally authored by not more than four authors.

Other:

Editorial, Guest Editorial, Commentary and Opinion are solicited by the editorial board.

References
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic numerals in superscript with square bracket after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.
The commonly cited types of references are shown here, for other types of references such as newspaper items please refer to ICMJE Guidelines (http://www.icmje.org or http://www.nlm.nih.gov/bsd/uniform_requirements.html).

Articles in Journals

Standard journal article (for up to six authors): Parija S C, Ravinder PT, Shariff M. Detection of hydatid antigen in the fluid samples from hydatid cysts by co-agglutination. Trans. R.Soc. Trop. Med. Hyg.1996; 90:255–256.
Standard journal article (for more than six authors): List the first six contributors followed by et al.

Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N. et al., Field Evaluation of a Rapid Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of Whole Blood. J. Clin. Microbiol. 2008; 46: 2022-2027.

Volume with supplement: Otranto D, Capelli G, Genchi C: Changing distribution patterns of canine vector borne diseases in Italy: leishmaniosis vs. dirofilariosis.Parasites & Vectors 2009; Suppl 1:S2.

Books and Other Monographs

Personal author(s): Parija SC. Textbook of Medical Parasitology. 3rd ed. All India Publishers and Distributors. 2008.
Editor(s), compiler(s) as author: Garcia LS, Filarial Nematodes In: Garcia LS (editor) Diagnostic Medical Parasitology ASM press Washington DC 2007: pp 319-356.
Chapter in a book: Nesheim M C. Ascariasis and human nutrition. In Ascariasis and its prevention and control, D. W. T. Crompton, M. C. Nesbemi, and Z. S. Pawlowski (eds.). Taylor and Francis,London, U.K.1989, pp. 87–100.

Electronic Sources as reference

Journal article on the Internet: Parija SC, Khairnar K. Detection of excretory Entamoeba histolytica DNA in the urine, and detection of E. histolytica DNA and lectin antigen in the liver abscess pus for the diagnosis of amoebic liver abscess .BMC Microbiology 2007, 7:41.doi:10.1186/1471-2180-7-41. http://www.biomedcentral.com/1471-2180/7/41

Tables

Tables should be self-explanatory and should not duplicate textual material.
Tables with more than 10 columns and 25 rows are not acceptable.
Number tables, in Arabic numerals, consecutively in the order of their first citation in the text and supply a brief title for each.
Place explanatory matter in footnotes, not in the heading.
Explain in footnotes all non-standard abbreviations that are used in each table.
Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡
Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text

Illustrations (Figures)

Upload the images in JPEG format. The file size should be within 1024 kb in size while uploading.
Figures should be numbered consecutively according to the order in which they have been first cited in the text.
Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.
Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen.
Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
When graphs, scatter-grams or histograms are submitted the numerical data on which they are based should also be supplied.
The photographs and figures should be trimmed to remove all the unwanted areas.
If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.
If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.
Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.
Final figures for print production: Send sharp, glossy, un-mounted, color photographic prints, with height of 4 inches and width of 6 inches at the time of submitting the revised manuscript. Print outs of digital photographs are not acceptable. If digital images are the only source of images, ensure that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. Send the images on a CD. Each figure should have a label pasted (avoid use of liquid gum for pasting) on its back indicating the number of the figure, the running title, top of the figure and the legends of the figure. Do not write the contributor/s' name/s. Do not write on the back of figures, scratch, or mark them by using paper clips.
The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size.

Protection of Patients' Rights to Privacy

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:

Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.
If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.

Sending a revised manuscript

The revised version of the manuscript should be submitted online in a manner similar to that used for submission of the manuscript for the first time. However, there is no need to submit the “First Page” or “Covering Letter” file while submitting a revised version. When submitting a revised manuscript, contributors are requested to include, the ‘referees’ remarks along with point to point clarification at the beginning in the revised file itself. In addition, they are expected to mark the changes as underlined or colored text in the article.

Reprints and proofs

Journal provides no free printed reprints. Authors can purchase reprints, payment for which should be done at the time of submitting the proofs.

Checklist

Covering letter

Signed by all contributors
Previous publication / presentations mentioned
Source of funding mentioned
Conflicts of interest disclosed

Authors

Last name and given name provided along with Middle name initials (where applicable)
Author for correspondence, with e-mail address provided
Number of contributors restricted as per the instructions
Identity not revealed in paper except title page (e.g. name of the institute in Methods, citing previous study as 'our study', names on figure labels, name of institute in photographs, etc.)

Presentation and format

Double spacing
Margins 2.5 cm from all four sides
Page numbers included at bottom
Title page contains all the desired information
Running title provided (not more than 50 characters)
Abstract page contains the full title of the manuscript
Abstract provided (structured abstract of 250 words for original articles, unstructured abstracts of about 150 words for all other manuscripts excluding letters to the Editor)
Key words provided (three or more)
Introduction of 75-100 words
Headings in title case (not ALL CAPITALS)
The references cited in the text should be after punctuation marks, in superscript with square bracket.
References according to the journal's instructions, punctuation marks checked
Send the article file without ‘Track Changes’

Language and grammar

Uniformly American English
Write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless it is a standard unit of measure. Numerals from 1 to 10 spelt out
Numerals at the beginning of the sentence spelt out
Check the manuscript for spelling, grammar and punctuation errors
If a brand name is cited, supply the manufacturer's name and address (city and state/country).
Species names should be in italics

Tables and figures

No repetition of data in tables and graphs and in text
Actual numbers from which graphs drawn, provided
Figures necessary and of good quality (colour)
Table and figure numbers in Arabic letters (not Roman)
Labels pasted on back of the photographs (no names written)
Figure legends provided (not more than 40 words)
Patients' privacy maintained (if not permission taken)
Credit note for borrowed figures/tables provided
Write the full term for each abbreviation used in the table as a footnote

Peer Review Policy

August 2022

International Journal of Clinicopathological Correlation, follows double blind peer review process with intention to publish good quality scientific papers. The journal reviewers play a vital role in maintaining the high standards of the International Journal of Clinicopathological Correlation, which is why all incoming manuscripts are peer reviewed following the procedure outlined below.

Initial manuscript evaluation

One of the Chief Editors first evaluates all submitted manuscripts for initial suitability for the publication based on novelty, relievance, originality and scientific rigor. Manuscripts rejected if they are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside the aims and scope of the journal. Those that meet the minimum criteria are normally passed on to at least two reviewers.

Authors of manuscripts rejected at this stage will usually be informed within two weeks of receipt.

Type of peer review

The International Journal of Clinicopathological Correlation employs ‘double blind’ reviewing, in which the reviewers remain anonymous to the author(s) throughout and following the review process, whilst the identity of the author(s) is likewise unknown to the reviewers.

How the reviwer is selected

Whenever possible, reviewers are matched to the paper according to their expertise. As our reviewer database is constantly being updated, we welcome suggestions for review from the author(s), though such non-binding recommendations are not necessarily used.

Review reports

Reviewers are asked to evaluate whether the manuscript:

Is original as to thought and method (including data)
Is methodologically sound
Has results which are clearly presented and support the conclusions
Correctly and exhaustively references previous relevant work
Follows appropriate ethical guidelines, especially as concerns plagiarism
Clearly adds to the knowledge and development of the field

Language correction is not part of the peer review process, but referees are encouraged to suggest corrections of language and style to the manuscript. In the final round, the handling Editor will check matters of linguistic and stylistic correctness, and may suggest or apply corrections at this point. In rare cases, the manuscript may be returned to the author(s) for a full linguistic and stylistic revision.

How long does the review process take?

The time required for the review process is dependent on the response of the reviewers. International Journal of Clinicopathological Correlation, the typical time for the first round of the review process is approximately 2 weeks, with a maximum of one month. Should the reviewers report contradict one another or a report is unnecessarily delayed, a further expert opinion may be sought. In the rare cases when it is extremely difficult to find a second reviewer to review the manuscript, whilst the one review extant report has thoroughly convinced the handling Editor, a decision to accept, reject or ask the author for a revision may be made, at the handling Editor’s discretion, on the basis of only one reviewer report. The handling Editor’s decision will be sent to the author with the reviewer recommendations, usually including the latter’s verbatim comments. As a rule, revised manuscripts are sent to the initial reviewer for checking; these may then request further revision.

Final report

A final decision to accept or reject the manuscript will be sent to the author along with the recommendations made by the reviewer, including (if applicable) the latter’s verbatim comments.

The Chief Editor's decision is final

Referees advise the Chief Editor, who is responsible for the final decision to accept or reject the article.

Open Access Publication and Creative Commons Licensing

Authors grant MM Publishers a License/Journal Publishing agreement to publish the article and identify itself as the original publisher.
Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
The Creative Commons - Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) formalizes these and other terms and conditions of publishing articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc/4.0/ or send a letter to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA.

All articles published by MM Publishers are made immediately available worldwide under the Open Access License. This means that everyone has free and unlimited access to full-text of all the articles, everyone is free to re-use the published material if proper accreditation/citation of the original publication is given;

Open access publication is supported by MM Publishers. International Journal of Clinicopathological Correlation currently has no Article Processing Charges. There are no submission charges for the articles.

The Journal provides for long-term digital preservation with direct upload of published articles into this website and through PKP Preservation network.

Journal follows open access policy under which copyright holder of a scholarly work published in journal grants usage rights to others using an open license (Creative Commons Attribution-NonCommercial 4.0 International License) allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose without asking prior permission from publisher or author

Copyright Policy

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Commons Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book or on their website or other repositories of the authors choice without embargo), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website or other repositories of the authors choice without embargo) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

How the journal will handle complaints and appeals

All complaints, appeals, and misbehavior allegations will be treated seriously, no matter if the parties are journal employees or not, or if the contribution in question was submitted before or after publication. Any claim submitted to the journal has to be forwarded to the publisher as well, who will handle the matter in accordance with the Committee on Publication Ethics' (COPE) rules.

The editor in chief will hear appeals of editorial decisions and will review the decision-making process to determine if an appeal is warranted. If the appeal is found to be legitimate, the editorial board and/or outside peer reviewers will be asked to conduct additional review until a new editorial decision may be made.

The journal is required to notify the relevant person's institution of any misconduct that is reported, confirmed, or highly suspected so that they can launch their own investigation. This covers both publication misconduct (such as manipulating the peer review process, plagiarism, editorial malpractice, etc.) and research misconduct (such as finishing study without ethical approval and consent, inventing or misrepresenting data, etc.). The publisher's correction policy will be adhered to in the event that the publishing record needs to be corrected.

To ensure optimal auditing, complaints must be sent via email. After a complaint is received, it will be acknowledged within three working days, and the complainant will be informed of the anticipated steps and deadlines during that time until a solution is reached. The head of the editorial team will examine and oversee the case if the complainant is not satisfied with the response and may request that the complaint be escalated.

In the event that accusations are made against an employee of the publishing company, senior management will be notified so they can oversee and evaluate the inquiry. If a conflict of interest emerges, the investigation may be directed by an impartial and independent person or people.

After the journal or publisher closes the case and the complaint is still not satisfied, the problem may be referred to COPE or another appropriate external organization. COPE will only take these complaints into consideration once a journal has used all of its internal complaint procedures.

If someone has any issues about the journal or its content and wants to file an appeal, file a complaint, or bring up possible misbehaviour, they should speak with the editor-in-chief and/or the editorial account manager of the publisher.

Journal policies on data sharing and reproducibility

The journal encourages data sharing, although it is generally not mandated for most articles typical of the system safety literature. However, the editor has the discretion to require data sharing based on the need for transparency and reproducibility. Data sharing requirements will be identified as early as possible in the review process.

If data sharing is required, the data should either be (a) published in a publicly available repository or (b) submitted as an auxiliary file with the IJCPC submission. Data should be cited according to standard IJCPC citation requirements.

Data shared with a manuscript must be anonymized and fully compliant with IJCPC ethics policies.

Journal’s policy on intellectual property

Rights and Responsibilities of Authors

Authors certify that their submitted manuscript (and any supporting materials) is their own intellectual property and that copyright has not been transferred to others.
Authors certify that the manuscript contains no plagiarism, fabrication, falsification, or manipulated citations and that it adheres to JSS authorship policies.
Authors certify that permission has been obtained from copyright holders to reproduce any copyrighted tables, figures, data, text, etc.
All manuscripts, revisions, drafts, and galleys remain the intellectual property of the author(s), who fully retain the copyright to their work.
Authors retain the full right to modify, reshare, repost, or archive any version of their copyrighted work.
Authors agree to keep all communications, comments, and reports between authors, reviewers, and editors confidential.

Responsibilities of Editorial Team

All review comments and reports remain the intellectual property of the reviewer or editor.
Reviewers and editors agree to keep all communications, comments, and reports between authors, reviewers, and editors confidential.
Reviewers and editors agree to keep all manuscripts, revisions, and drafts confidential, except for the final published galley(s).

Advertising Policy

International Journal of Clinicopathological Correlation (IJCPC) does not accept advertisements currently.

Funding Source
International Journal of Clinicopathological Correlation (IJCPC) is funded by MM India Medical Services Private Limited.

About the Journal

Make a Submission

ISSN -Online: 2589-1731

MM Publications